To subscribe to our optical e-newsletters and receive them via e-mail, click here.
As diabetes becomes more common, a large unmet need has arisen for long-acting corticsteroid implants to treat the disorder.
A look at the improvements in instrumentation and technologies that are reducing surgical risks and improving visual outcomes.
After nearly a decade of use, what the data says about the ocular and systemic safety of these increasingly used drugs.
This uncommon but potentially devastating eye infection needs to be diagnosed and managed promptly.
Despite shifts in treatment options, scleral buckle remains an excellent choice to treat rhegmatogenous retinal detachment.
Advanced imaging techniques may lead to timely diagnosis and more effective treatment of hydroxychloroquine-related toxicity.
Central serous chorioretinopathy afflicts working-age patients. While many can be observed, some will require intervention.
This therapeutic revolution has important implications for health policy, for physicians and most importantly, for patients.
On the anniversary of the consensus guidelines, a look at what evidence gathered over the decade has taught us.
Copyright© 2000 - 2015 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.